Home
Akebia Therapeutics AKBA spent $480K on lobbying in Q1 2026 · Health Issues, Medicare
Trade details
- Type
- Lobbying report
- Amount
- $480,000
- Quarter
- Q1 2026
- Client
- Akebia Therapeutics
- Reported
- 26/04/20
Up 84.6% from last quarter
What else happened in Akebia Therapeutics around then
Filed or reported within 30 days of the trade day · 03/01~04/30Akebia Therapeutics's other lobbying reports
- Akebia Therapeutics
LobbyingAkebia Therapeutics
LobbyingAkebia Therapeutics
AKBA
$360K
$360K
Reported 07/20
for Q2
- Akebia Therapeutics
LobbyingAkebia Therapeutics
LobbyingAkebia Therapeutics
AKBA
$60K
$60K
Reported 07/20
for Q2
- Akebia Therapeutics
LobbyingAkebia Therapeutics
LobbyingAkebia Therapeutics
AKBA
$60K
$60K
Reported 07/13
for Q2
- Akebia Therapeutics
LobbyingAkebia Therapeutics
LobbyingAkebia Therapeutics
AKBA
$60K
$60K
Reported 04/20
for Q1
- Akebia Therapeutics
LobbyingAkebia Therapeutics
LobbyingAkebia Therapeutics
AKBA
$45K
$45K
Reported 04/05
for Q1